Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate-Reference-Cited by-同舟云学术

Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate

Published:2017-06-16 Issue:9 Volume:72 Page:2483-2488
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Both Anna,Büttner Henning,Huang Jiabin,Perbandt Markus,Belmar Campos Cristina,Christner Martin,Maurer Florian P.,Kluge Stefan,König Christina,Aepfelbacher Martin,Wichmann Dominic,Rohde Holger

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/9/2483/19540401/dkx179.pdf

Reference39 articles.

1. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts;Euro Surveill,2010

2. Global spread of carbapenemase-producing Enterobacteriaceae;Emerg Infect Dis,2011

3. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Lancet Infect Dis,2013

4. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors;Curr Opin Microbiol,2011

5. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study;Lancet Infect Dis,2016

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients;Journal of Antimicrobial Chemotherapy;2024-08-19

2. Crystal structure of the class A extended-spectrum β-lactamase CTX-M-96 in complex with relebactam at 1.03 Angstrom resolution;Antimicrobial Agents and Chemotherapy;2024-08-07

3. Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan;International Journal of Antimicrobial Agents;2024-08

4. MultiRapid ATB NP test for detecting concomitant susceptibility and resistance of last-resort novel antibiotics available to treat multidrug-resistant Enterobacterales infections;International Journal of Antimicrobial Agents;2024-08

5. Mecanismos moleculares y epidemiología de la resistencia a ceftazidima-avibactam: un análisis integral;Acta Pediátrica de México;2024-07-25